14
ATCC 39920菌種， 馬鏈球菌獸疫亞種
Streptococcus equi subsp. zooepidemicus Farrow and Collins (ATCC®39920™)
| Strain Designations | HA-116 |
|---|---|
| Application | Produces hyaluronic acid Production of high molecular weight hyaluronic acid |
| Isolation | Nitrosoguanidine-induced mutant of clinical isolate HA-100 |
| Type Strain | no |
| Biosafety Level | 2 |
| Product Format | freeze-dried |
| Storage Conditions | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol® | no ATCC 39920菌種， 馬鏈球菌獸疫亞種 |
|---|---|
| Type Strain | no |
| Medium | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC ® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
|---|---|
| Growth Conditions | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor | Biotechnology General Corp. |
|---|---|
| Isolation | Nitrosoguanidine-induced mutant of clinical isolate HA-100 |
| References | Nimrod A, et al. Method of producing high molecular weight sodium hyallronate by fermentation of Streptococcus. US Patent 4,780,414 dated Oct 25 1988 Nimrod A, et al. High molecular weight sodium hyaluronate. US Patent 4,784,990 dated Nov 15 1988 |
